ArticleFrontiers in pharmacology2025
Ginger (
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ginger as a nutraceutical shield: Counteracting acrylamide-induced liver injury.World journal of hepatology · 2026Article
- Ginger mitigates acrylamide-induced hepatotoxicity through antioxidant and anti-inflammatory mechanisms in rats.World journal of hepatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oxidative stress and impaired antioxidant defenses contribute significantly to liver dysfunction, particularly with aging. This study evaluated the dose- and age-dependent effects of dietary ginger ( Methods: Male Swiss Webster mice aged 3, 6, and 12 months (n = 48 per age group) received standard feed or feed supplemented with either 0.6% or 1.8% dried ginger powder for 3 months. Liver tissue was analyzed for multiple antioxidant parameters, including DPPH radical scavenging activity, total antioxidant capacity, vitamin C levels, total phenolic content, superoxide dismutase (SOD) activity, malondialdehyde (MDA) levels, and reduced glutathione (GSH) concentrations. Results: The results demonstrated significant age-dependent declines in several antioxidant parameters in control animals, including DPPH scavenging activity, total antioxidant capacity, vitamin C levels, total phenolic content, and SOD activity. Ginger supplementation produced differential effects based on both dose and age. While 3-month-old mice showed decreased DPPH radical scavenging with ginger supplementation, both 6- and 12-month-old mice exhibited significantly increased activity. Higher-dose (1.8%) ginger supplementation enhanced GSH levels across all age groups, with effects being most pronounced in older mice. SOD activity remained unaffected by ginger supplementation across all groups. MDA levels were significantly reduced by 1.8% ginger supplementation in 3-month-old mice, with smaller, dose-dependent but non-significant reductions in older groups. Discussion: These findings demonstrate that ginger's effects on liver antioxidant systems are both dose- and age-dependent, with generally stronger beneficial effects observed at higher doses and in older animals. The observed dose- and age-dependent variations emphasize the importance of personalized supplementation strategies and provide a foundation for future research into the molecular mechanisms underlying ginger's antioxidant effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.